Literature DB >> 31511219

[Prediction of rectal toxicity of radiotherapy for prostate cancer based on multi-modality feature and multi-classifiers].

Qiang He1, Xuetao Wang2, Xin Li1, Xin Zhen1.   

Abstract

OBJECTIVE: To evaluate rectal toxicity of radiotherapy for prostate cancer using a novel predictive model based on multi-modality and multi-classifier fusion.
METHODS: We retrospectively collected the clinical data from 44 prostate cancer patients receiving external beam radiation (EBRT), including the treatment data, clinical parameters, planning CT data and the treatment plans. The clinical parameter features and dosimetric features were extracted as two different modality features, and a subset of features was selected to train the 5 base classifiers (SVM, Decision Tree, K-nearest-neighbor, Random forests and XGBoost). To establish the multi-modality and multi-classifier fusion model, a multi-criteria decision-making based weight assignment algorithm was used to assign weights for each base classifier under the same modality. A repeat 5-fold cross-validation and the 4 indexes including the area under ROC curve (AUC), accuracy, sensitivity and specificity were used to evaluate the proposed model. In addition, the proposed model was compared quantitatively with different feature selection methods, different weight allocation algorithms, the model based on single mode single classifier, and two integrated models using other fusion methods.
RESULTS: Repeated (5 times) 5-fold cross validation of the proposed model showed an accuracy of 0.78 for distinguishing toxicity from non-toxicity with an AUC of 0.83, a specificity of 0.79 and a sensitivity of 0.76.
CONCLUSIONS: Compared with the models based on a single mode or a single classifier and other fusion models, the proposed model can more accurately predict rectal toxicity of radiotherapy for prostate cancer.

Entities:  

Keywords:  multi-classifier; multi-criteria decision-making; multi-modality; prostate cancer radiotherapy; rectal toxicity

Mesh:

Year:  2019        PMID: 31511219      PMCID: PMC6765590          DOI: 10.12122/j.issn.1673-4254.2019.08.15

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  17 in total

1.  Prediction models: revolutionary in principle, but do they do more good than harm?

Authors:  Andrew J Vickers
Journal:  J Clin Oncol       Date:  2011-06-20       Impact factor: 44.544

2.  Classifier Fusion With Contextual Reliability Evaluation.

Authors:  Zhunga Liu; Quan Pan; Jean Dezert; Jun-Wei Han; You He
Journal:  IEEE Trans Cybern       Date:  2017-06-08       Impact factor: 11.448

Review 3.  Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening.

Authors:  Robert A Smith; Kimberly S Andrews; Durado Brooks; Stacey A Fedewa; Deana Manassaram-Baptiste; Debbie Saslow; Otis W Brawley; Richard C Wender
Journal:  CA Cancer J Clin       Date:  2018-05-30       Impact factor: 508.702

4.  Identification of a rectal subregion highly predictive of rectal bleeding in prostate cancer IMRT.

Authors:  Gaël Dréan; Oscar Acosta; Juan D Ospina; Auréline Fargeas; Caroline Lafond; Gwenaelle Corrégé; Jean-L Lagrange; Gilles Créhange; Antoine Simon; Pascal Haigron; Renaud de Crevoisier
Journal:  Radiother Oncol       Date:  2016-05-09       Impact factor: 6.280

5.  Deep convolutional neural network with transfer learning for rectum toxicity prediction in cervical cancer radiotherapy: a feasibility study.

Authors:  Xin Zhen; Jiawei Chen; Zichun Zhong; Brian Hrycushko; Linghong Zhou; Steve Jiang; Kevin Albuquerque; Xuejun Gu
Journal:  Phys Med Biol       Date:  2017-10-12       Impact factor: 3.609

6.  Multi-objective radiomics model for predicting distant failure in lung SBRT.

Authors:  Zhiguo Zhou; Michael Folkert; Puneeth Iyengar; Kenneth Westover; Yuanyuan Zhang; Hak Choy; Robert Timmerman; Steve Jiang; Jing Wang
Journal:  Phys Med Biol       Date:  2017-05-08       Impact factor: 3.609

7.  Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer.

Authors:  D W Nathan Kim; L Chinsoo Cho; Christopher Straka; Alana Christie; Yair Lotan; David Pistenmaa; Brian D Kavanagh; Akash Nanda; Patrick Kueplian; Jeffrey Brindle; Susan Cooley; Alida Perkins; David Raben; Xian-Jin Xie; Robert D Timmerman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-07-01       Impact factor: 7.038

8.  Assessing correlations between the spatial distribution of the dose to the rectal wall and late rectal toxicity after prostate radiotherapy: an analysis of data from the MRC RT01 trial (ISRCTN 47772397).

Authors:  Florian Buettner; Sarah L Gulliford; Steve Webb; Matthew R Sydes; David P Dearnaley; Mike Partridge
Journal:  Phys Med Biol       Date:  2009-10-14       Impact factor: 3.609

9.  Association between EBRT dose volume histograms and quality of life in prostate cancer patients.

Authors:  Anna Boladeras; Ferran Ferrer; Valentin Navarro; Rodolfo De Blas; Oriol Cunillera; David Mateo; Cristina Gutierrez; Evelyn Martinez; Salvador Villà; Joan Pera; Montse Ferrer; Ferran Guedea
Journal:  Rep Pract Oncol Radiother       Date:  2018-08-13

10.  Investigating rectal toxicity associated dosimetric features with deformable accumulated rectal surface dose maps for cervical cancer radiotherapy.

Authors:  Jiawei Chen; Haibin Chen; Zichun Zhong; Zhuoyu Wang; Brian Hrycushko; Linghong Zhou; Steve Jiang; Kevin Albuquerque; Xuejun Gu; Xin Zhen
Journal:  Radiat Oncol       Date:  2018-07-06       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.